Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Omada, a virtual healthcare provider, announced Tuesday that it is expanding its GLP-1 companion solution to include musculoskeletal exercise programming and member-level reporting for employers, ...

Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of members in its GLP-1 companion program. By extending ...

・Morgan Stanley, Evercore ISI, and Barclays raised price targets to between $28–$32, citing Omada’s revenue growth and its first positive adjusted EBITDA. ・The company plans to integrate GLP-1 ...

COPENHAGEN, Denmark, Dec. 4, 2025 /PRNewswire/ -- Omada A/S ("Omada"), a global leader in Identity Governance and Administration (IGA), today unveiled its long-term strategic vision: delivering ...

The virtual chronic care company said in a press release that 7.9 million shares are being sold in the offering, amounting to $150 million. Omada, founded in 2012, will trade on the Nasdaq under the ...

Omada Health (OMDA) on Monday said preliminary, unaudited revenue for the fourth quarter of 2025 is expected to be between ...

Omada has reached a large scale in terms of patient eligibility, and now Amazon is stepping in to help it enhance its scale for patient enrollment as well, Duffy explained. He doesn’t think Amazon ...

Omada Health plans to raise up to $158 million in its up coming IPO, attaining a market cap of about $1.1 billion at the top end of its expected range, according to a filing on Thursday. The virtual ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...

Omada Health priced its IPO at $19 per share on Thursday, in the middle of the expected range. The virtual chronic care company said in a press release that 7.9 million shares are being sold in the ...